GLP-1glp-1cardiologyeuropean heart journalesc

European Heart Journal issue covers GLP-1 agonists and myocarditis mechanisms

The editorial rounds up new ESC guidance alongside treatment insights spanning mineralocorticoid receptor antagonists, cardiac glycosides and incretin therapy.

By Maren Holt · Senior Reporter, GLP-1

Oct 8 20:00 ETSource: European heart journal

The wire

01European Heart Journal's issue editorial by Crea highlights ESC Guidelines plus papers on myocarditis mechanisms and treatment with GLP-1 receptor agonists, MRAs and cardiac glycosides.
02Cardiometabolic prescribers tracking incretin use in heart disease get a curated pointer to the underlying journal papers.
03Only the editorial framing is given here; the specific GLP-1 findings, endpoints and study designs sit in the referenced articles.

From the source

ESC Guidelines, mechanisms of myocarditis, novel insights into treatment with mineralcorticoid receptor antagonists, cardiac glycosides, and GLP-1 receptor agonists
European heart journal · 2026 Oct 9 · Crea F et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42853674/